SCHEMBL9563382

SCHEMBL9563382

O=[N+]([O-])c1ccccc1OC/C=C/CN1CCC(OC(c2ccsc2)c2ccsc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.39
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP2D6 P10635 3/20 0.38
CYP2C19 P33261 3/20 0.38
KDM4E B2RXH2 1/20 0.38
BCHE P06276 1/20 0.36
CYP1A2 P05177 2/20 0.36
NPC1 O15118 1/20 0.36
RECQL P46063 1/20 0.36
SCD O00767 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.34
ALDH1A1 P00352 2/20 0.33
LTA4H P09960 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9563293 1.00 RAB9A (0.39) RAB9APOLBL3MBTL1CYP2D6CYP2C19
SCHEMBL9563287 1.00 RAB9A (0.39) RAB9APOLBL3MBTL1CYP2D6CYP2C19
SCHEMBL9563387 0.89 BCHE (0.45) RAB9APOLBL3MBTL1CYP2D6CYP2C19
SCHEMBL9563341 0.89 BCHE (0.45) RAB9APOLBL3MBTL1CYP2D6CYP2C19
SCHEMBL9563344 0.89 BCHE (0.45) RAB9APOLBL3MBTL1CYP2D6CYP2C19
SCHEMBL9563219 0.84 CYP2D6 (0.54) RAB9AL3MBTL1CYP2D6CYP2C19KDM4E
SCHEMBL9563246 0.84 SLC6A3 (0.34) CYP2D6BCHE
SCHEMBL9563196 0.84 SLC6A3 (0.34) CYP2D6BCHE
SCHEMBL9563201 0.84 SLC6A3 (0.34) CYP2D6BCHE
Hydrochloric Acid SCHEMBL9563346 0.84 CYP2D6 (0.53) RAB9AL3MBTL1CYP2D6CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0529365-A1 Diarylmethoxypiperidine derivatives Kaken Pharmaceutical Co., Ltd. (JP) 1993-03-03 EP disclosed
US-5190959-A Antihistamines, antiallergens, treatment of ischemic heart disease KAKEN PHARMACEUTICAL CO. LTD. (JP) 1993-03-02 US disclosed